Application of jaceosidin in preparation of drugs used for preventing or treating pulmonary fibrosis

A technology of palm cyanidin and pulmonary fibrosis, which is applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc.

Active Publication Date: 2014-03-26
安徽格太信控科技有限公司
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Palm cyanidin is a single compound extracted from Artemisia argyi [Tang Shengan, Sun Liang, Zhai Huiyuan, Duan Hongquan, Zhang Yanwen. Research on the chemical constituents of Artemisia argyi. Journal of Tianjin Medical University, 2011, 17(4): 461-463.], Palm cyanidins have anti-inflammatory effects [Clavin M, G

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of jaceosidin in preparation of drugs used for preventing or treating pulmonary fibrosis

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0010] Preparation Example 1: Preparation of palm cyanidin

[0011] 1kg of dried Artemisia argyi leaves was crushed, heated and refluxed with 6 times the amount of 95% ethanol for 3 times, each time for 6 hours, filtered, combined the filtrate, concentrated under reduced pressure to extract the extract, added an appropriate amount of distilled water to suspend, and dissolved in 10L Extract with ethyl acetate in a separatory funnel, collect the extract and separate it with silica gel column chromatography (silica gel 600g, 300-400 mesh), and use CH2Cl2→CH2Cl2:EtoAc (5:1→2:1)→EtoAc→MeOH in sequence Gradient elution, combined similar components by TLC, and passed through a silica gel column with normal pressure to obtain 460 mg of palmicyanidin.

Embodiment 2

[0012] Embodiment 2 palm cyanidin tablet preparation

[0013] Weigh 20.0g palm cyanidin, 55.0g powdered sugar, 100.0g lactose and 23.0g sodium carboxymethyl starch, mix well and pass through a 100-mesh sieve, add an appropriate amount of 3% PVP K30 Appropriate amount of water solution to make soft material, granulate with 20-mesh sieve, dry at 60°C for 3 hours, granulate with 18-mesh sieve, add 2.0g of magnesium stearate, mix evenly, punch with shallow concave, and adjust the tablet weight to about 200mg.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides novel pharmaceutical purposes of jaceosidin and specifically relates to application of jaceosidin in prevention or treatment of pulmonary fibrosis, wherein through inhibition of pulmonary epithelial-mesenchymal transition, pulmonary vascular endothelial-mesenchymal transition and propagation of fibroblasts, growth and development of pulmonary fibrosis are inhibited, so prevention or treatment of pulmonary fibrosis is realized. In the above-mentioned application, the dosage range of applied jaceosidin is 20 to 1000 mg, preferably, 20 to 500 mg.

Description

technical field [0001] The invention relates to palm cyanidin inhibiting the occurrence and development of pulmonary fibrosis so as to prevent or treat pulmonary fibrosis; specifically, palm cyanidin inhibits lung epithelial cell-mesenchymal transition and pulmonary vascular endothelial cell-mesenchymal transition, inhibits The abnormal activation of pulmonary fibroblasts can inhibit the occurrence and development of pulmonary fibrosis, so as to prevent or treat pulmonary fibrosis. Background technique: [0002] Idiopathic pulmonary fibrosis (IPF), also known as cryptogenic fibrosing alveolitis (CFA), is a chronic inflammatory interstitial disease. (usual interstitialpneumonia, UIP) is a characteristic pathological change with unknown etiology. The main manifestations are that the appearance of fibroblastic foci leads to the deposition of a large amount of extracellular matrix (ECM), the accumulation of collagen, and the destruction of alveolar structure, which eventually l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/352A61P11/00
Inventor 蒋王林亢泽春
Owner 安徽格太信控科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap